Lipopolysaccharides (LPS) anticorps
-
- Antigène Voir toutes Lipopolysaccharides (LPS) Anticorps
- Lipopolysaccharides (LPS)
-
Reactivité
- Bactérie à Gram négatif
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Lipopolysaccharides (LPS) est non-conjugé
-
Application
- Immunofluorescence (IF)
- Specificité
- Recognizes LPS. Cross-reactive with numerous members of the Enterobacteriaciae: Pseudomonas aeruginosa, Klebsiella pneumoniae, E. coli O157, Salmonella enteriditis, Enterobacter aerogenes, E. hermanii, Yersinia enterocolitica and Shigella sonnei.
- Purification
- Ion exchange chromatography
- Immunogène
-
Whole cell prep of Lipid A from E. coli O157.
Type of Immunogen: Cells - Isotype
- IgG
- Top Product
- Discover our top product Lipopolysaccharides (LPS) Anticorps primaire
-
-
- Indications d'application
-
Approved: IF
Usage: Suitable for use in Immunofluorescence. Tested with whole organisms in IF. - Commentaires
-
Target Species of Antibody: Gram Negative Bacteria
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.2, 0.09 % sodium azide. No stabilizing proteins added.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- avoid freeze thaw cycles. Store undiluted.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles. Store undiluted.
-
-
A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy." dans: Cancers, Vol. 15, Issue 17, (2023) (PubMed).
: "A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy." dans: Cancers, Vol. 14, Issue 5, (2022) (PubMed).
: "Purification and characterization of lipopolysaccharides from six strains of non-O157 Shiga toxin-producing Escherichia coli." dans: Journal of microbiological methods, Vol. 116, pp. 1-7, (2015) (PubMed).
: "Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens." dans: Antimicrobial agents and chemotherapy, Vol. 58, Issue 2, pp. 966-77, (2014) (PubMed).
: "
-
A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy." dans: Cancers, Vol. 15, Issue 17, (2023) (PubMed).
-
- Antigène
- Lipopolysaccharides (LPS)
- Autre désignation
- Lipopolysaccharide / LPS (Lipopolysaccharides (LPS) Produits)
- Classe de substances
- Chemical
- Sujet
-
Name/Gene ID: LPS
Synonyms: LPS
-